Jan 02, 2019
The promise and dangers of editing the genome of a human embryo are being discussed by scientists around the world. They are contemplating whether it should be allowed or not— and if so, under what circumstances? The meetings have been prompted by the powerful technology known as CRISPR/Cas9. This could be use...
Read More...
Discover How Learning Disability Treatment Landscape is Evolving with the Emergence of Digital Assistant Technologies
Jul 04, 2025
A New Era for Multiple Myeloma Treatment: Bispecific Antibodies Enter the Fray
Jun 10, 2025
LEQEMBI: A New Hope for Alzheimer’s Disease Patients
Feb 12, 2025
-Agonist.png "Toll-like Receptors Agonist")
Newsletter/Whitepaper